ACVRL1 and cancer: During tumorigenesis, bone morphogenetic protein 9 (BMP-9)/activin receptor-like kinase 1 (ALK-1) signals negatively regulate lymphatic formation [160], suggesting that BMP-9/ALK-1 signals have potential as a target for cancer therapy.